Nutrition & Exercise Prehabilitation for Cancer Patients

This study is looking at a 3-week program for American Indian cancer patients before they start their main cancer treatment. The program involves eating 60 grams of walnuts daily and doing two 60-minute supervised exercise sessions each week. Researchers want to see if this program is practical and acceptable to patients, and if it can change certain inflammatory markers (signs of inflammation in the body) in their blood and tissue. You can join if you are 18-80 years old, have any type of cancer, are scheduled for treatment at least 3 weeks away, receive care at San Carlos Apache Healthcare Corporation (SCAHC), can eat walnuts, and can do moderate exercise. The study is currently recruiting about 30 participants.

Study design
This is a single-arm study, meaning everyone receives the same intervention, and plans to enroll 30 participants.
What's involved
You would participate in a 3-week program involving daily walnut consumption and two weekly supervised exercise sessions, along with baseline and post-intervention measurements including blood samples.
Compensation
Not stated in the trial record.
Follow-up
Measurements are taken at baseline and post-intervention (an average of 5 weeks), with adherence to the protocol measured for 3 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06644560

A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients

Recruiting
NAAges 18–80InterventionalPrevention
University of Arizona
~30 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:Prehabilitation Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient enrollment and retention: proportion of patients who initiate the intervention, provide pre-intervention measurements and return for post-intervention measurements
Measured over Baseline and post-intervention (an average of 5 weeks)
+8 more outcomes measured
Cancer
1 sites across 1 states
Arizona1
  • Jennifer Erdrich, MD · PRINCIPAL_INVESTIGATOR · University of Arizona

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18-80 years
Diagnosed with cancer of any kind
Scheduled at least 3 weeks out from first treatment
Receiving care at San Carlos Apache Healthcare Corporation (SCAHC)
Able to eat walnuts
Able to do moderate-intensity exercise

Exclusion

Digestive tract disease that would restrict diet modifications
Allergy to the foods intended for the nutrition intervention
Uncontrolled cardiac disease or other contraindications to moderate-intensity exercise
  • Patient enrollment and retention: proportion of patients who initiate the intervention, provide pre-intervention measurements and return for post-intervention measurementsBaseline and post-intervention (an average of 5 weeks)

    Primary endpoint: determining feasibility of the prehabilitation intervention by measuring patient reported acceptability via patient enrollment and retention. Patient retention will be estimated as the proportion of patients who initiate the intervention, provide pre-intervention measurements and return for post-intervention measurements, with an exact 95% binomial confidence interval.

  • Adherence to study protocol: compliance with intervention foods (walnuts)3 weeks during participant's preoperative window

    Primary endpoint: determining feasibility of the prehabilitation intervention by measuring patient reported acceptability via compliance with intervention foods (walnuts). Compliance with intervention foods (walnuts) will be estimated as the number of daily packets eaten/number distributed, with an exact 95% binomial confidence interval.

  • Adherence to study protocol: compliance with exercise recommendations3 weeks during participant's preoperative window

    Primary endpoint: determining feasibility of the prehabilitation intervention by measuring patient reported acceptability via compliance with exercise recommendations. Compliance with exercise recommendations will be estimated as the increase in daily steps (as measured by pedometers) post- versus pre-intervention using a 95% confidence interval.

  • Assessing patient acceptability via exit interviews to solicit patient experience and feedback3 weeks during participant's post-intervention assessment

    Primary endpoint: determining feasibility of the prehabilitation intervention by measuring patient reported acceptability via exit interviews. The exit interviews will provide qualitative data for assessment. The interview transcriptions will be coded and themed. Themes will be vetted with SCAHC staff to ensure shared understanding of concepts and accurate representation of community perspective.

  • Comparison of pre/post-intervention 6 Minute Walk Test Scores to assess lifestyle behavioral changeBaseline and post-intervention assessment (an average of 3 weeks)

    Primary endpoint: determining feasibility of the prehabilitation intervention by measuring lifestyle behavioral changes via the 6 Minute Walk Test scores. The score of the 6MWT is the distance a patient walks in 6 minutes. Pre/post intervention performance changes on the 6MWT will be estimated using 95% confidence intervals, with transformation as needed to induce normality.

  • Comparison of pre/post-intervention sit-to-stand test scores to assess lifestyle behavioral changeBaseline and post-intervention assessment (an average of 3 weeks)

    Primary endpoint: determining feasibility of the prehabilitation intervention by measuring lifestyle behavioral changes via the sit-to-stand test scores. The sit-to-stand test score is the total number of stands within 30 seconds (more than halfway up at the end of 30 seconds counts as a full stand). Pre/post intervention performance changes on the sit-to-stand test will be estimated using 95% confidence intervals, with transformation as needed to induce normality.

  • Comparison of pre/post-intervention patient responses to the Dietary Screener QuestionnaireBaseline and post-intervention assessment (an average of 3 weeks)

    Primary endpoint: determining feasibility of the prehabilitation intervention by measuring lifestyle behavioral changes via comparing pre/post- intervention responses to the Dietary Screener Questionnaire. The Dietary Screener Questionnaire has 30 questions. There is a scoring algorithm that converts the responses to estimates of dietary intake of fruits and vegetables, dairy, added sugar, whole grain, fiber, and calcium. Changes between pre and post intervention will be estimated using 95% confidence intervals, with transformation as needed to induce normality.

  • Comparison of pre/post-intervention patient responses to the Arizona Activity QuestionnaireBaseline and post-intervention assessment (an average of 3 weeks)

    Primary endpoint: determining feasibility of the prehabilitation intervention by measuring lifestyle behavioral changes via comparing Arizona Activity Questionnaire. The Arizona Activity Questionnaire has 14 sections with 77 line items. There is a formula that converts the responses to estimates of total energy expenditure and physical activity energy expenditure. Changes between pre and post intervention will be estimated using 95% confidence intervals, with transformation as needed to induce normality.

  • Assessing biosample collection rates: percentage of patients completing blood and tissue sample collectionBaseline and post-intervention assessment (an average of 3 weeks)

    Primary endpoint: determining feasibility of the prehabilitation intervention by assessing percentage of patients who complete blood and tissue sample collections. Biosample collection rates (plasma and tissue) will be estimated as the proportion of patients who provide biospecimens at the pre- and post-intervention visits, with exact 95% binomial confidence intervals.